Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

One of our scientists, Dr Hannah Bolland, has become a virtual teacher, connecting school students with science.

Dr Hannah Bolland is a post-doctoral researcher working with Professor Ester Hammond, and has also taken on the role as a biology teacher with AimHi.

Hannah was selected to give a series of video lessons to students from around the world. The first lesson, ‘What is Cancer’, streamed live on 27 May and is still available on the AimHi YouTube Channel.

In 28 mins, Hannah explored the Hayflick limit, mutations, the growth of cancer and even some pathology slides. The students were constantly engaged contributing comments through the chat feature. Her session ends with why we should love naked mole rats! 

Hannah did a fantastic job, introducing new material, annotating live on the slide, and responding to questions in the interactive  chat feature. The lesson was a dynamic mixture of ideas, pictures, audience input, and quizzes. Hannah’s next session will talk about diagnosis.

 

 

 

 

 

 

AimHi

AimHi was started by Matthew Shribman, former PhD student at Oxford’s Department of Chemistry, and Henry Waite, an Oxford chemistry graduate.

Aware that schools were closing round the world, they set out to put students in contact with exceptional teachers with expert knowledge. School students are provided with the chance to interact with scientists and explore topics from space to dinosaurs, and, in Hannah’s case, cancer.

Similar stories

The Department represented at the European Radiation Research Society annual conference

Researchers from the Department of Oncology attend the prestigious European Radiation Research Society (ERRS) in annual conference in Catania, Italy to present their research in Radiation Oncology.

Funding to research metformin’s ability to delay or prevent cancers driven by the mutated TP53 gene

A research project embedded within the Metformin in Li Fraumeni (MILI) trial will investigate metformin’s mechanism of action when taken as a preventative for mTP53-driven cancers.

Cancer patients remain at higher risk of severe COVID-19 disease despite third dose booster vaccine

A large population-level assessment reveals third dose COVID-19 vaccination is effective for most patients with cancer, but effectiveness is lower than in the general population, particularly in patients who have undergone recent chemotherapy and those with lymphoma.

Time-varying nature of clinical risk factors for pancreatic cancer may aid earlier diagnosis

Body mass index, blood tests, comorbidities and medication use are temporally associated with cancer risk in the three years before a pancreatic cancer diagnosis.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.